Literature DB >> 23829463

The effect of hematocrit on bioanalysis of DBS: results from the EBF DBS-microsampling consortium.

Ronald de Vries1, Matthew Barfield, Nico van de Merbel, Bernhard Schmid, Christoph Siethoff, Jordi Ortiz, Elwin Verheij, Ben van Baar, Zoe Cobb, Steve White, Philip Timmerman.   

Abstract

BACKGROUND: The European Bioanalysis Forum dried blood spots (DBS)/microsampling consortium is reporting back from the experiments they performed on further documenting the potential hurdles of the DBS technology. This paper is focused on the impact of hematocrit changes on DBS analyses.
RESULTS: The hematocrit can have an effect on the size of the blood spot, on spot homogeneity and on extraction recovery in a compound-dependent manner. The extraction recovery can change upon aging in an hematocrit-dependent way. Different card materials can give different outcomes.
CONCLUSIONS: The results from the conducted experiments show that the issues of DBS in regulated bioanalysis are real and that the technology will need improvements to be ready for use as a general tool for regulated bioanalysis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23829463     DOI: 10.4155/bio.13.170

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  9 in total

1.  Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group.

Authors:  Christopher Evans; Mark Arnold; Peter Bryan; Jeffrey Duggan; Christopher A James; Wenkui Li; Steve Lowes; Luca Matassa; Timothy Olah; Philip Timmerman; Xiaomin Wang; Enaksha Wickremsinhe; John Williams; Eric Woolf; Patricia Zane
Journal:  AAPS J       Date:  2014-12-09       Impact factor: 4.009

2.  Performance and storage integrity of dried blood spots for PCB, BFR and pesticide measurements.

Authors:  Stuart Batterman; Sergei Chernyak
Journal:  Sci Total Environ       Date:  2014-07-21       Impact factor: 7.963

3.  Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots.

Authors:  Daniel Gonzalez; Chiara Melloni; Brenda B Poindexter; Ram Yogev; Andrew M Atz; Janice E Sullivan; Susan R Mendley; Paula Delmore; Amy Delinsky; Kanecia Zimmerman; Andrew Lewandowski; Barrie Harper; Kenneth C Lewis; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.695

4.  Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer.

Authors:  A E C A B Willemsen; L M Knapen; Y M de Beer; R J M Brüggemann; S Croes; C M L van Herpen; N P van Erp
Journal:  Eur J Clin Pharmacol       Date:  2017-12-08       Impact factor: 2.953

5.  Analysis of the Heterogeneous Distribution of Amiloride and Propranolol in Dried Blood Spot by UHPLC-FLD and MALDI-IMS.

Authors:  Beatriz Uribe; Oskar González; María Encarnación Blanco; Oihane Elena Albóniga; María Luz Alonso; Rosa María Alonso
Journal:  Molecules       Date:  2019-11-26       Impact factor: 4.411

6.  Validation and Clinical Application of a Liquid Chromatography-Ultraviolet Detection Method to Quantify Dolutegravir in Dried Blood Spots.

Authors:  Abdulafeez Akinloye; Oluwasegun Eniayewu; Babatunde Adeagbo; Oluseye Bolaji; Adeniyi Olagunju
Journal:  Ther Drug Monit       Date:  2022-06-01       Impact factor: 3.118

Review 7.  Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples.

Authors:  Nick Verougstraete; Veronique Stove; Alain G Verstraete; Christophe P Stove
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

8.  Influence of Hematocrit and Total-Spot Volume on Performance Characteristics of Dried Blood Spots for Newborn Screening.

Authors:  Elizabeth M Hall; Sharon R Flores; Víctor R De Jesús
Journal:  Int J Neonatal Screen       Date:  2015-08-21

9.  Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review.

Authors:  Shoshana Revel-Vilk; Maria Fuller; Ari Zimran
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.